RPRXRoyalty PharmaHealth Care
$60.85EarningsNov 4, 2026
1D—1W—1M—3M—1Y—
Market cap$34.1BCompany infoRevenue$2.4B52-wk range$35 – $62IndustryBiotechnologyWebsiteroyaltypharma.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +69.4% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E34.4×3039
11
151
P / S14.0×56
7
11
P / FCF12.8×7588
5
13
EV / EBITDA24.0×2028
12
60
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin100.0%100100
100%
100%
Operating margin67.9%99100
14%
84%
Net margin33.9%9396
2%
51%
ROE12.6%4655
1%
19%
ROIC9.9%5456
2%
15%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity1.302516
0.9
1.4
Net debt / EBITDA4.7×168
Current ratio2.667965
Interest coverage4.9×4339
Per shareTTM, with year-over-year change
Revenue / share$4.36▲ +8%
EPS (diluted)$1.77▼ −24%
FCF / share$4.74▼ −2%
Est. EPS growth (fwd)—